Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 250 participants.
Also called NCT05007925
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 250 participants
- Sponsor
- Registry
-
NCT05007925
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Germany
- Registry status
- Completed
Technical summary
Registry record NCT05007925. Allocation not applicable; no masking; primary purpose treatment. Start 2021-11-18 (actual); primary completion 2024-03-25 (actual). Results posted on 2025-08-05.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Disrupt PAD BTK II Study With the Shockwave Peripheral IVL System
- Condition
- Peripheral Artery Disease
- Intervention (Device)
- Intravascular Lithotripsy
- Lead sponsor
- Shockwave Medical, Inc.
Record details
- Record id
cardio:ct-nct05007925- Content hash
6d2eabaa591c0c16ece892666c964a8625a4903229ef55def282dbe190c5e01e